A. Rozman (Golnik, Slovenia), F. Gamarra (Munich, Germany)
Relevance of clinical TNM-staging in small cell lung cancer (SCLC) for survival – A retrospective case study in 633 patients
T. Blum, J. Kollmeier, W. Grüning, N. Schönfeld, D. Misch, T. Bauer (Berlin, Germany)
|   |
The relation between clinical tumor stage and metastasis according to sixth TNM staging and new revised TNM staging in non-small lung cancer patients
H. Ozkan Yilmaz, D. Marasli, A. Saygi, Y. Düzgün, A. Orki, H. Koksal (Istanbul, Turkey)
| |
A thorough mediastinoscopy does not preclude an accurate remediastinoscopy
S. Call, R. Rami-Porta, C. Obiols, M. Serra-Mitjans, G. Gonzalez-Pont, R. Bastus-Piulats, J. Belda (Spain)
| |
Mediastinal staging in lung cancer: A rational approach
L. Ceron, L. Michieletto, A. Zamperlin (Mestre, Italy)
| |
Utility of PET/CT in staging of lung cancer: Results from 245 patients
A. Bugge, A. Naalsund, A. Sundset, A. Berstad, G. Mynarek, J. G. Fjeld, J. Kongerud, M. B. Lund (Norway)
| |
Clinical and pathologic staging – PET/CT impact
A. P. Vaz, G. Fernandes, C. Souto Moura, P. Bastos, H. Queiroga, V. Hespanhol (Oporto, Portugal)
| |
The surveillance of recurred/refractory lung malignancy using whole-body MRI: Correlation with the results assessed by PET-CT
M. H. Lee, S. R. Kim, S. J. Park, K. H. Min, H. Moon, H. J. Han, C. R. Chung, K. H. Choi, E. J. Lee, H. B. Lee, Y. K. Rhee, G. Y. Jin, Y. C. Lee (Jeonju, Republic Of Korea)
| |
The comparison of CT and PET findings with diagnostic accuracy of TTNB in thoracic lesions
N. Demir Firat, I. Savas (Ankara, Turkey)
| |
Synchronous primary malignancies identified during staging 18F-FDG PET scan in lung cancer patients
A. Dushianthan, A. Bhatta, J. A. Benjamin (Llantrisant, United Kingdom)
| |
The importance of positron emission tomography/computed tomography (PET-CT) to identify distant metastasis in non-small cell lung cancer (NSCLC)
A. Durmaz, M. Kiyik, H. C. E. M. Tigin, M. T. Karadeli, C. Akyüz, A. Çelik, H. Özyurt, S. Çikrikçioglu (Istanbul, Turkey)
| |
FDG-PET is superior to conventional CT in predicting histologic responses after induction therapy for locally advanced NSCLC
A. Maeda, K. Yasuda, M. Nakata (Kurashiki, Japan)
| |
Radiological features of primary lung cancer subtypes at Tygerberg Academic Hospital, Cape Town, South Africa; a one year retrospective review
A. B. Nanguzgambo, K. Aubeelack, F. von Groote-Bidlingmaier, S. M. Hattingh, M. Louw, C. T. Bolliger (Cape Town, South Africa)
| |
Tumour metabolic-flow difference as a potential predictor of survival in non-small cell lung cancer (NSCLC)
T. Win, M. Shastry, R. Endozo, S. Janes, I. Kayni, P. Ell, K. Miles, A. Groves (Stevenage, , Brighton, United Kingdom)
| |
Quantitative tumor perfusion assessment with 64-slice multidetector-row CT (MDCT): Evaluation before and after antiangiogenic chemotherapy
N. Tacelli, M. Remy-Jardin, A. Scherpereel, J. J. Laffite, A. L. Hachulla, J. Remy (Lille Cedex, France)
| |
EGFR mutations analysis in CT-guided transthoracic fine-needle aspiration samples
A. Antunes, J. Gomes, L. Cirnes, R. Fernandes, J. C. Machado, B. Parente (Vila Nova Gaia, Porto, Portugal)
| |
EGFR and KRAS mutational profiling in NSCLC cells obtained through fine needle aspiration cytology (FNAC)
G. M. Stella, M. Zorzetto, S. Inghilleri, R. Scabini, F. Cemmi, P. Morbini, R. Dore, L. Maurizio, E. Pozzi (Pavia, Italy)
| |
Analysis of prognostic factors in patients with stage IIIB, IV non-small cell lung cancer
S. Arinc, A. Hazar, M. Ertugrul, F. Ece, N. Erdal, N. Hatabay (Istanbul, Turkey)
| |
The accuracy of the predicted postoperative pulmonary function in patients undergoing lung resection
A. van de Looi, Y. Berk, M. Keemers, Y. Heijdra, F. van Vollenhoven, J. Janssen (Nijmegen, Heerenveen, Netherlands)
| |